Compass Pathways Plc
$ 12.08
5.87%
12 Jun - close price
- Market Cap 1,526,277,000 USD
- Current Price $ 12.08
- High / Low $ 12.37 / 11.45
- Stock P/E N/A
- Book Value 2.42
- EPS -3.14
- Next Earning Report 2026-07-30
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.26 %
- ROE -0.69 %
- 52 Week High 14.76
- 52 Week Low 2.25
About
COMPASS Pathways plc is a mental health care company in the United Kingdom and the United States. The company is headquartered in Cheshire, the United Kingdom.
Analyst Target Price
$22.20
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-13 | 2026-03-24 | 2025-11-04 | 2025-07-31 | 2025-05-08 | 2025-02-27 | 2024-10-31 | 2024-08-01 | 2024-05-08 | 2024-02-29 | 2023-11-02 | 2023-08-03 |
| Reported EPS | -0.3 | -0.6065 | -0.38 | -0.41 | -0.42 | -0.63 | -0.56 | -0.56 | -0.55 | -0.53 | -0.67 | -0.62 |
| Estimated EPS | -0.31 | -0.3973 | -0.4 | -0.37 | -0.49 | -0.63 | -0.59 | -0.55 | -0.49 | -0.34 | -0.42 | -0.7 |
| Surprise | 0.01 | -0.2092 | 0.02 | -0.04 | 0.07 | 0 | 0.03 | -0.01 | -0.06 | -0.19 | -0.25 | 0.08 |
| Surprise Percentage | 3.2258% | -52.6554% | 5% | -10.8108% | 14.2857% | 0% | 5.0847% | -1.8182% | -12.2449% | -55.8824% | -59.5238% | 11.4286% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-30 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | -0.49 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CMPS
2026-06-06 00:40:15
This article provides a stock chart for COMPASS PATHWAYS PLC (NASDAQ:CMPS) on ChartMill.com. It displays the current stock price, daily changes, and after-hours trading information. The page also offers various trading tools and market data for analysis.
2026-06-05 12:39:29
Compass Pathways plc announced that it granted equity awards to seventeen newly hired non-executive employees under its 2026 Inducement Plan. These awards, consisting of options and restricted share units, were granted on June 1, 2026, and are designed to vest over a four-year period, subject to continued employment. The grants comply with Nasdaq Listing Rule 5635(c)(4) and aim to attract and retain talent in the biotechnology company focused on mental health innovation.
/filters:format(webp)https://news.stocktwits-cdn.com/large_Getty_Images_2194622714_jpg_c18475d557.webp)
2026-06-05 12:39:29
Compass Pathways PLC (CMPS) shares rose over 23% pre-market after the company announced its COMP360 drug successfully met the primary endpoint in a Phase 3 clinical trial for treatment-resistant depression (TRD). The company stated COMP360, a proprietary psilocybin formulation, demonstrated statistically significant and clinically meaningful reduction in symptom severity with a well-tolerated and safe profile. Compass plans to submit a New Drug Application (NDA) in Q4 after discussing with the FDA, aiming for commercial launch of COMP360 for TRD by year-end.
2026-06-05 11:39:55
Compass Pathways plc announced it granted equity awards to seventeen new non-executive employees under its 2026 Inducement Plan. These awards, consisting of options and restricted share units, were made on June 1, 2026, as a material inducement for their employment. The grants comply with NASDAQ Listing Rule 5635(c)(4) and were approved by the Compensation and Leadership Development Committee.
2026-06-05 10:39:42
Compass Pathways plc announced that it granted equity awards to seventeen newly hired non-executive employees under its 2026 Inducement Plan. These awards, consisting of options to purchase 157,000 shares and restricted share units or nominal cost options covering 74,700 shares, were made on June 1, 2026. The grants, approved by the Compensation and Leadership Development Committee, serve as a material inducement for their employment, in accordance with NASDAQ Listing Rule 5635(c)(4) and have vesting periods spanning four years.
2026-06-05 10:30:29
Compass Pathways plc announced equity awards granted to seventeen newly hired non-executive employees under the Nasdaq Listing Rule 5635(c)(4). These grants, issued on June 1, 2026, include options for 157,000 shares and restricted share units/nominal cost options covering 74,700 shares, with vesting periods subject to continued employment. The awards were approved by the Compensation and Leadership Development Committee as a material inducement for employment.
